Stryker Corporation (SYK) earnings
SYK earnings moved a median of -0.05% by the close. Quarterly and annual SYK reports and results, each read against the price at its own news timestamp. Back to the SYK overview →
24 measured SYK earnings events.
Where these SYK earnings landedvs 24 measured SYK earnings reactions
| Middle 50% of SYK earnings reactions | -1.09% to +0.71% |
|---|---|
| Median reaction (to close) | -0.05% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 SYK earnings events with a measured close landed between -1.09% and +0.71%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Stryker to announce third quarter 2026 financial results | Press release | +0.58% | -1.03% | |
| Form 10-Q STRYKER CORP For: Jun 30 | SEC filing · Form 10-Q | +0.09% | +0.34% | |
| Stryker reports second quarter 2026 operating results | Press release | -1.16% | +0.21% | |
| Stryker to announce second quarter 2026 financial results | Press release | +0.28% | -1.19% | |
| Form 10-Q STRYKER CORP For: Mar 31 | SEC filing · Form 10-Q | +0.02% | +0.10% | |
| Stryker reports first quarter 2026 operating results | Press release | -1.30% | -4.93% | |
| Form 10-K STRYKER CORP For: Dec 31 | SEC filing · Form 10-K | -0.24% | +0.86% | |
| Form 10-Q STRYKER CORP For: Sep 30 | SEC filing · Form 10-Q | +0.05% | -1.12% | |
| Stryker reports third quarter 2025 operating results | Press release | -0.14% | -3.17% | |
| Form 10-Q STRYKER CORP For: Jun 30 | SEC filing · Form 10-Q | -0.22% | -0.95% | |
| Stryker reports second quarter 2025 operating results | Press release | -0.10% | -1.08% | |
| Form 10-Q STRYKER CORP For: Mar 31 | SEC filing · Form 10-Q | +0.40% | +0.81% | |
| Stryker reports first quarter 2025 operating results | Press release | -0.94% | +1.16% | |
| Form 10-K STRYKER CORP For: Dec 31 | SEC filing · Form 10-K | +0.17% | -0.38% | |
| Form 10-Q STRYKER CORP For: Sep 30 | SEC filing · Form 10-Q | +0.08% | +1.26% | |
| Stryker reports third quarter 2024 operating results | Press release | -0.38% | -1.15% | |
| Stryker to announce its third quarter 2024 financial results | Press release | -0.45% | +0.04% | |
| Form 10-Q STRYKER CORP For: Jun 30 | SEC filing · Form 10-Q | -0.46% | -0.15% | |
| Stryker reports second quarter 2024 operating results | Press release | -2.85% | -0.92% | |
| Form 10-Q STRYKER CORP For: Mar 31 | SEC filing · Form 10-Q | -0.15% | +0.65% | |
| Stryker reports first quarter 2024 operating results | Press release | -1.60% | -1.64% | |
| Form 10-K STRYKER CORP For: Dec 31 | SEC filing · Form 10-K | +0.04% | +1.58% | |
| Form 10-Q STRYKER CORP For: Sep 30 | SEC filing · Form 10-Q | +0.09% | +1.46% | |
| Stryker reports third quarter 2023 operating results | Press release | -1.85% | +0.68% |
Keep exploring
More SYK: analyst actions → · SEC filings → · SYK overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CONATUS PHARMACEUTICALS INC (CNAT) | 492 | -0.22% | 44% |
| Midatech Pharma PLC - American Depositary Shares (MTP) | 492 | 0.00% | 41% |
| Agios Pharmaceuticals, Inc. (AGIO) | 490 | +0.16% | 55% |
| TEARLAB CORP (TEAR) | 488 | 0.00% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.